NO983100L - 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity - Google Patents

4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity

Info

Publication number
NO983100L
NO983100L NO983100A NO983100A NO983100L NO 983100 L NO983100 L NO 983100L NO 983100 A NO983100 A NO 983100A NO 983100 A NO983100 A NO 983100A NO 983100 L NO983100 L NO 983100L
Authority
NO
Norway
Prior art keywords
dihydronaphth
derivatives
cisoxazoles
cns activity
compounds
Prior art date
Application number
NO983100A
Other languages
Norwegian (no)
Other versions
NO983100D0 (en
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO983100D0 publication Critical patent/NO983100D0/en
Publication of NO983100L publication Critical patent/NO983100L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Abstract

4,5-dihydronafth[l,2-c ] isoxazol- derivater av generell formel (I) hvori A, X og n er som definert og beskrevet her. Slike forbindelser er anvendbare som serotonin 5-HT,- antagonister. Disse forbindelser er anvendbare ved behandling av angst, psykiatriske forstyrrelser, kvalme, brekninger og legemiddelavhengighet.4,5-dihydronaphth [1,2-c] isoxazole derivatives of general formula (I) wherein A, X and n are as defined and described herein. Such compounds are useful as serotonin 5-HT 1 antagonists. These compounds are useful in the treatment of anxiety, psychiatric disorders, nausea, vomiting and drug addiction.

NO983100A 1996-01-05 1998-07-03 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity NO983100L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Publications (2)

Publication Number Publication Date
NO983100D0 NO983100D0 (en) 1998-07-03
NO983100L true NO983100L (en) 1998-09-04

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983100A NO983100L (en) 1996-01-05 1998-07-03 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity

Country Status (14)

Country Link
EP (1) EP0874833A1 (en)
JP (1) JP3161737B2 (en)
KR (1) KR100308748B1 (en)
CN (1) CN1214046A (en)
AR (1) AR005347A1 (en)
AU (1) AU710059B2 (en)
BR (1) BR9612578A (en)
CA (1) CA2241845C (en)
HU (1) HUP9903706A3 (en)
IL (1) IL125197A0 (en)
NO (1) NO983100L (en)
NZ (1) NZ325587A (en)
WO (1) WO1997025317A1 (en)
ZA (1) ZA9725B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8656101A (en) * 2000-08-21 2002-03-04 Univ Georgetown 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
EA008189B1 (en) * 2002-04-02 2007-04-27 Янссен Фармацевтика Н.В. Substituted amino isoxazoline derivatives and their use as anti-depressants
AR040967A1 (en) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv TRICYCLIC C-SUBSTITUTED ISOXAZOLINE DERIVATIVES AND ITS USE AS ANTI-DEPRESSIVE
ES2339444T3 (en) 2002-08-15 2010-05-20 Janssen Pharmaceutica Nv CONDENSED HETEROCICLIC ISOXAZOLINE DERIVATIVES AND ITS USE AS ANTIDEPRESSANTS.
MY134287A (en) 2002-08-21 2007-11-30 Janssen Pharmaceutica Nv C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
EP2597089A1 (en) 2009-10-29 2013-05-29 Bristol-Myers Squibb Company Tricyclic heterocyclic compounds
CN110234633A (en) 2016-09-02 2019-09-13 百时美施贵宝公司 Substituted tricyclic heterocyclic compounds
WO2019032632A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company Alkylphenyl compounds
WO2019032631A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company Oxime ether compounds
KR102002633B1 (en) 2018-07-19 2019-07-22 김태효 Non slip foot wear with separating cushion part
KR102429797B1 (en) 2019-12-31 2022-08-05 주식회사 제이패션 Functional non-sewn overshoes and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
DE69021645T2 (en) * 1989-05-19 1996-02-22 Hoechst Roussel Pharma N- (aryloxyalkyl) heteroarylpiperidines and heteroarylpiperazines, processes for their preparation and their use as medicaments.
US5670522A (en) * 1992-10-23 1997-09-23 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands

Also Published As

Publication number Publication date
NO983100D0 (en) 1998-07-03
CA2241845A1 (en) 1997-07-17
AR005347A1 (en) 1999-04-28
AU1412697A (en) 1997-08-01
ZA9725B (en) 1997-07-07
KR19990077033A (en) 1999-10-25
CN1214046A (en) 1999-04-14
BR9612578A (en) 1999-07-27
JP3161737B2 (en) 2001-04-25
CA2241845C (en) 2002-10-01
HUP9903706A3 (en) 2000-09-28
AU710059B2 (en) 1999-09-09
IL125197A0 (en) 1999-03-12
NZ325587A (en) 1999-02-25
WO1997025317A1 (en) 1997-07-17
HUP9903706A2 (en) 2000-08-28
KR100308748B1 (en) 2001-12-12
EP0874833A1 (en) 1998-11-04
JPH11510816A (en) 1999-09-21

Similar Documents

Publication Publication Date Title
AU6944091A (en) Indole-substituted five-membered heteroaromatic compounds
DK0491664T3 (en) Indole derivatives as serotonin antagonists
CA2086434A1 (en) Quinuclidine derivatives
NO983100L (en) 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity
DK1302207T3 (en) Process for preparing an antihypertensive agent containing a dipeptide as an effective ingredient
GR3026008T3 (en) Ampa antagonists and a method of treatment therewith
ES2152379T3 (en) CONDENSED DIHYDROPIRIDINS AND ITS USE FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS.
NO974155D0 (en) A novel process for the preparation of 2,3-dihydrobenzofuranol derivatives
AP2002002595A0 (en) Heterocyclic amide derivatives.
TW358807B (en) Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole
PT889044E (en) DERIVATIVES OF 5- (HETEROARIL) ALTAL-3-OXO-PYRID- (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE (GDP) USEFUL IN TREATING PERTURBACTIONS OF THE CENTRAL NERVOUS SYSTEM
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
MY135750A (en) N-sulfonylaminothiazole
CA2275299A1 (en) Indane or dihydroindole derivatives
HUP0002895A2 (en) 3-azabicyclo[3.1.0]hexanes, method for producing the same, and their use
NO20012538L (en) Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders
EP0686641A4 (en) 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug
AU3499189A (en) Tricyclic ketones Patent to Lapse
MX9703899A (en) Arylacrylamide derivatives.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application